Saint Francis Health System Surgery Research evaluates innovative surgical techniques, minimally invasive procedures, vascular interventions, and medical devices designed to improve patient outcomes. Through participation in prospective clinical trials and post-market research studies, our surgeons help advance evidence-based surgical care while offering eligible patients access to emerging treatment options.
DEFIANCE- NCT05701917 PI: Tucker Harrison, DO
Prospective, Multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. 1:1, ClotTriever Intervention Arm or Conservative Medical Management Arm.
ArtixASCEND- NCT07135895 PI: Andres Guerra, MD
Prospective, post-market, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions. The Artix All-in-one Solution for Complete thrombEctomy With eNDovascular Approach
Study Details | NCT07135895 | The ArtixASCEND Study | ClinicalTrials.gov
PERFORMANCE III- NCT05845710 PI: John Weber, MD
A prospective, multicenter, single-arm, open-label study evaluating the safety and effectiveness of the Neuroguard IEP® Direct System for the treatment of carotid artery stenosis in subjects at elevated risk for carotid endarterectomy (CEA).